Hypothesis

Age-related decline in gut microbial production of NAD+ precursors diminishes neuronal SIRT1 activity, blunting autophagy activation during fasting and accelerating brain aging; restoring microbial NAD+ salvage rescues fasting‑induced autophagy and cognition.

Mechanistic Rationale

Fasting triggers hepatic ketone release and gut hormone spikes (NPY, ghrelin) that activate neuronal autophagy via Y1/Y2/Y5 and GHS‑R1a receptors [[https://www.aging-us.com/article/100996/text]]. Autophagy depends on NAD+‑driven SIRT1 deacetylation of autophagy proteins (e.g., LC3, ATG5) [[https://pubmed.ncbi.nlm.nih.gov/30172870/]]. The gut microbiome supplies extracellular nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) that host cells absorb via nucleoside transporters [[https://pmc.ncbi.nlm.nih.gov/articles/PMC12995645/]]. With aging, dysbiosis reduces Lactobacillus and Bifidobacterium strains known to synthesize NR/NMN, lowering luminal NAD+ precursor availability [[https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2024.1362239/full]]. Consequently, neuronal SIRT1 activity falls despite fasting‑induced hormone signaling, attenuating autophagy and allowing accumulation of damaged mitochondria and protein aggregates.

This creates a double hit: (1) diminished microbial NAD+ precursors limit the substrate for SIRT1, and (2) age‑related gut inflammation raises LPS/LBP, driving microglial activation via TLR4 [[https://med.stanford.edu/news/all-news/2026/03/gut-brain-cognitive-decline.html]]. The vagus nerve, already compromised by inflammatory signaling, fails to relay the full parasympathetic boost that normally amplifies gut‑brain metabolic coupling.

Predictions and Experimental Design

1. Metabolite deficit – Aged mice will show ~40% lower fecal NR/NMN levels than young controls; fasting will not restore these levels in aged microbiota.
2. Microbiota transfer – Germ‑aged mice receiving fecal microbiota from young, fasted donors will exhibit restored fecal NR/NMN, increased hippocampal SIRT1 activity, elevated LC3‑II/I ratio, and improved performance in the Morris water maze compared with germ‑aged mice receiving aged microbiota.
3. Enzymatic blockade – Supplementing aged mice with NR alone will fail to boost brain autophagy if the microbial nicotinamide phosphoribosyltransferase (NAPT) gene is knocked out via CRISPR‑Cas9 in the transplanted microbiota, confirming the microbial source.
4. Vagal dependence – Subdiaphragmatic vagotomy will abolish the cognitive rescue despite restored microbial NAD+ precursors, linking the gut‑brain neural arm to the metabolic effect.

Measurements: fecal LC‑MS for NR/NMN, Western blot for SIRT1, p‑ACCS, LC3‑II/I in hippocampal lysates, immunofluorescence for LBP and Iba1, electrophysiological vagal tone, and behavioral assays.

Potential Implications

If validated, this hypothesis reframes inflammaging as partly a microbiota‑driven NAD+ deficiency that sabotages the autophagy‑boosting power of fasting. It suggests combinatorial interventions: timed fasting paired with microbial NAD+ precursor producers (e.g., engineered B. fragilis expressing NAPT) or prebiotics that favor NR‑synthesizing strains. Such strategies could be tested in human pilot trials by tracking plasma NAD+ metabolites, fecal microbiomics, and cognitive scores before and after intermittent fasting regimens.

By targeting the microbial arm of the gut‑brain axis, we may break the vicious loop where brain dysfunction worsens gut ecology, and instead harness fasting’s full neuroprotective potential.